KRISTIN BOWMAN: Open Payments
NPI 1427457803 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 34 payments from 10 companies in 2025. Trend: 2023 $436 · 2024 $521 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $209 |
| Alkermes, Inc. | 10 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Corium, LLC | 2 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, ARISTADA, CAPLYTA, COBENFY, HETLIOZ, VRAYLAR, Auvelity, Azstarys.
Industry payments across KY — which companies pay providers there.
